Placeholder

Pricing — The Cost of Doing Business

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 1761. Categories: , .

Product Description

Pick up a newspaper, turn on the television, or log onto the Internet and almost every week, a politician, agency, or consumer group can be found criticizing the pharmaceutical industry’s pricing, promotional, or marketing practices.
Central to the controversy, more often than not, is the cost of pharmaceutical products and the impact this cost has on healthcare expenditures and on consumers’ wallets.
“Drug companies have products to sell and they want to maximize their value within each segment of the market,” says Jim Czaban, an attorney in the Washington, D.C., office of Heller Ehrman White & McAuliffe. “Criticisms of the industry’s drug-pricing policies often are politically motivated. When people say drug pricing is not rational, it’s often a code…

Sidebar:
Prescription Drug Prices On The Rise
The Rising Cost of Drug Development
DTC Promotion: A Handy Scapegoat

Experts on this topic
James N. Czaban. Attorney, Heller Ehrman White & McAuliffe LLP, Washington, D.C.; Heller Ehrman is a law firm
Joseph A. Dimasi, Ph.D. Director of Economic Analysis, Tufts Center for the Study of Drug Development, Boston; the Tufts Center for the Study of Drug Development is an independent, academic, nonprofit, research group affiliated with Tufts University Families USA. Washington, D.C.; Families USA is a national nonprofit, non-partisan organization dedicated to the achievement of high-quality, affordable health and long-term care for all Americans
Edward M. Feaver, Pharm.D. President and CEO, Prescription Solutions, Costa Mesa, Calif.; Prescription Solutions, a wholly owned subsidiary of PacifiCare Health Systems Inc., is a pharmacy and medical management company that manages the prescription drug benefit of commercial, Medicare, and governmental health plans, as well as those of employers and unions representing 5 million members nationwide and $1.9 billion in pharmaceutical purchases
Harris Interactive Inc. Rochester, N.Y.; Harris Interactive is a worldwide market research and consulting firm
Kenneth I Kaitin, Ph.D. Director, Tufts Center for the Study of Drug Development, Boston, and assistant professor of pharmacology and experimental therapeutics at Tufts University School of Medicine; the Tufts Center for the Study of Drug Development is an independent, academic, nonprofit, research group affiliated with Tufts University
The Henry J. Kaiser Family Foundation. Washington, D.C.; the Kaiser Family Foundation is an independent, national health philanthropy dedicated to providing information and analysis on health issues to policy makers, the media, and the general public
Irwin Lerner. CEO, Reliant Pharmaceuticals LLC, Liberty Corner, N.J.;                           Reliant is a privately held pharmaceutical company
Dr. Merrill Matthews. Visiting Scholar, Institute for Policy Innovation, Lewisville, Texas; IPI is a non-profit, non-partisan public policy “think tank” founded in 1987 to research, develop, and promote innovative and non-partisan solutions to today’s public policy problems
Thomas Nagle, Ph.D. Chairman, Strategic Pricing Group Inc., Waltham, Mass.; Strategic Pricing Group provides value-based pricing and marketing strategy development for business-to-business and business-to-consumer markets
Pharmacy Benefit Management Institute Inc. Tempe, Ariz.; PBMI provides information and educational services focused on the pharmacy benefit management industry
Public Citizen. Washington, D.C.; Public Citizen is a national, nonprofit consumer advocacy organization founded by Ralph Nader in 1971 to represent consumer interests in Congress, the executive branch, and the courts
Stuart Schweitzer, Ph.D. Professor, Health Services, Director, Ph.D. and M.S. Programs, UCLA School of Public Health, Los Angeles, Calif.; the learning objectives of the Department of Health Services are to teach concepts to advance the health of populations by improving the effectiveness and efficiency of personal and other health services in private and public health organizations
Jeff Trewhitt. Pharmaceutical Research and Manufacturers of America, Washington, D.C.; PhRMA represents the country’s leading research-based pharmaceutical and biotechnology companies
David L. Webster, Ph.D. President, Founder, The Webster Consulting Group Inc., Bethlehem, Pa.; the Webster Consulting Group provides management consulting services to the pharmaceutical, biotechnology, and medical industries

FEEDBACK